These 10 ERα-negative and 10 ERα-positive breast tumours have been selected from a previously tested breast tumours series where the ERα status was determined at the protein level by biochemical methods and quantified by ERα real-time quantitative RT–PCR assay (Bièche et al, 2001). Here, ESR1 is linked to breast neoplasm.